293 related articles for article (PubMed ID: 24967523)
1. Associations between statin adherence level, health care costs, and utilization.
Zhao Y; Zabriski S; Bertram C
J Manag Care Spec Pharm; 2014 Jul; 20(7):703-13. PubMed ID: 24967523
[TBL] [Abstract][Full Text] [Related]
2. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
[TBL] [Abstract][Full Text] [Related]
3. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
[No Abstract] [Full Text] [Related]
4. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
Watanabe JH; Kazerooni R; Bounthavong M
J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
[TBL] [Abstract][Full Text] [Related]
6. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.
Pittman DG; Chen W; Bowlin SJ; Foody JM
Am J Cardiol; 2011 Jun; 107(11):1662-6. PubMed ID: 21439533
[TBL] [Abstract][Full Text] [Related]
7. Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency.
Latremouille-Viau D; Guerin A; Gagnon-Sanschagrin P; Dea K; Cohen BG; Joseph GJ
J Manag Care Spec Pharm; 2017 Feb; 23(2):214-224. PubMed ID: 28125373
[TBL] [Abstract][Full Text] [Related]
8. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
[TBL] [Abstract][Full Text] [Related]
9. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not.
Chang HY; Kan HJ; Shermock KM; Alexander GC; Weiner JP; Kharrazi H
J Manag Care Spec Pharm; 2020 Oct; 26(10):1282-1290. PubMed ID: 32996394
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
11. Primary nonadherence to statin medications in a managed care organization.
Cheetham TC; Niu F; Green K; Scott RD; Derose SF; Vansomphone SS; Shin J; Tunceli K; Reynolds K
J Manag Care Pharm; 2013 Jun; 19(5):367-73. PubMed ID: 23697474
[TBL] [Abstract][Full Text] [Related]
12. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
Ye X; Gross CR; Schommer J; Cline R; St Peter WL
Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
[TBL] [Abstract][Full Text] [Related]
13. Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study.
Schleyer T; Hui S; Wang J; Zhang Z; Knapp K; Baker J; Chase M; Boggs R; Simpson RJ
J Manag Care Spec Pharm; 2019 May; 25(5):544-554. PubMed ID: 31039062
[TBL] [Abstract][Full Text] [Related]
14. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
Mitra D; Hodgkins P; Yen L; Davis KL; Cohen RD
BMC Gastroenterol; 2012 Sep; 12():132. PubMed ID: 23006789
[TBL] [Abstract][Full Text] [Related]
15. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
16. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
Jung K; McBean AM; Kim JA
J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
[TBL] [Abstract][Full Text] [Related]
17. Is there a relationship between early statin compliance and a reduction in healthcare utilization?
Aubert RE; Yao J; Xia F; Garavaglia SB
Am J Manag Care; 2010 Jun; 16(6):459-66. PubMed ID: 20560689
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
[TBL] [Abstract][Full Text] [Related]
19. Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study.
Li YC; Huang WL
Biomed Res Int; 2015; 2015():149573. PubMed ID: 26539464
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
Mucha L; Shaohung S; Cuffel B; McRae T; Mark TL; Del Valle M
J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]